Pediatric medication errors: predicting and preventing tenfold disasters

G Koren1, R H Haslam

  • 1Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.

Insights

Tenfold dosing errors in pediatrics are common due to small volumes, communication issues, and illegible handwriting. Implementing unit dosing and removing hazardous drugs from wards can significantly reduce these medication errors.

Area of Science:

  • Pediatric pharmacology
  • Medication safety
  • Clinical pharmacy

Background:

  • Tenfold errors in pediatric medication dosing are a significant concern.
  • These errors are more prevalent in children because required volumes are small, masking large discrepancies.
  • Adult dosing is less susceptible due to the large, noticeable volumes that errors would produce.

Purpose of the Study:

  • To identify common sources of tenfold medication errors in pediatric care.
  • To explore strategies for mitigating calculation and communication errors in pediatric drug administration.
  • To assess the potential of unit-dose systems in reducing medication errors.

Main Methods:

  • Analysis of common causes for tenfold dosing errors in pediatric patients.
  • Review of existing practices in academic institutions for calculation verification.
  • Discussion of transition to unit-dose systems and ward stock management.

Main Results:

  • Pediatric tenfold errors are linked to small stock volumes, parental communication challenges, and physician handwriting illegibility.
  • Independent double-checking and disagreement resolution mechanisms are standard in academic settings.
  • Transitioning to patient's unit dose is expected to decrease calculation errors, as pharmacists exhibit fewer errors.

Conclusions:

  • Pediatric tenfold dosing errors pose a substantial risk, influenced by volume, communication, and prescription clarity.
  • Systemic changes, including unit dosing and optimized drug availability on wards, are crucial for enhancing pediatric medication safety.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...